Introduction to the UK Modern Slavery Act 2015

The UK Modern Slavery Act 2015 is landmark legislation aimed at combatting modern slavery and human trafficking. It requires businesses operating in the UK, with a turnover exceeding £36 million, to publish an annual slavery and human trafficking statement. This statement must outline the steps taken to ensure that slavery and human trafficking are not taking place in their own operations and supply chains. Although Prowa Medical Instruments’ turnover currently falls below this threshold, we voluntarily uphold the principles and standards set forth by the Act to promote ethical practices and mitigate risks associated with modern slavery.

a. Organisation’s Structure, Business, and Supply Chains

Prowa Medical Instruments is headquartered in Sialkot, Pakistan, specializing in the manufacturing of high-quality surgical instruments. Our operations encompass the entire production cycle, from design and sourcing of raw materials to manufacturing, distribution, and customer service. We engage with a global network of suppliers and subcontractors to ensure adherence to stringent quality and ethical standards throughout our supply chains.

Our Policies on Slavery and Human Trafficking

At Prowa Medical Instruments, we have implemented robust policies to prohibit slavery and human trafficking in all aspects of our operations and supply chains. These policies are designed to:

• Clearly define our zero-tolerance approach to slavery and human trafficking.
• Establish guidelines for ethical sourcing and procurement practices.
• Outline expectations for compliance with all applicable laws and regulations, including the UK Modern Slavery Act 2015.
• Ensure that our suppliers and subcontractors adhere to similar ethical standards through contractual obligations and audits.

b. Due Diligence and Assessing and Managing Risk

We conduct thorough due diligence processes to assess and mitigate risks related to slavery and human trafficking within our supply chains. Our approach includes:

• Conducting risk assessments to identify high-risk areas within our operations and supply chains.
• Evaluating potential suppliers and subcontractors based on ethical criteria, including labor practices and human rights.
• Implementing supplier codes of conduct and contractual agreements that prohibit the use of forced labor and exploitation.
• Performing regular audits and site visits to monitor compliance and address any identified risks promptly.

Assurance and Key Performance Indicators

Prowa Medical Instruments measures the effectiveness of our efforts to prevent slavery and human trafficking through key performance indicators (KPIs) and assurance mechanisms, including:

• Monitoring compliance with our policies and contractual obligations through internal audits and supplier assessments.
• Conducting regular reviews of our supply chain transparency and ethical sourcing practices.
• Providing training and capacity-building programs for employees to raise awareness and enhance understanding of human rights issues, including slavery and human trafficking.
• Engaging with stakeholders, including customers and civil society organizations, to ensure transparency and accountability in our supply chain management practices.

Conclusion

Prowa Medical Instruments remains committed to upholding ethical standards and promoting responsible business practices in accordance with the UK Modern Slavery Act 2015. Through continuous improvement and collaboration with stakeholders, we strive to create a supply chain that is free from modern slavery and human trafficking, thereby contributing to a more sustainable and equitable global economy.